1109 Remegen trading
BioCentury & Getty Images

Finance

RemeGen’s value surpasses $4B after pricing 2020’s largest biotech IPO

Nov 10, 2020 | 12:51 AM GMT

After raising nearly HK$4 billion ($514.3 million) in the year’s largest

Read the full 330 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE